Annual D&A
$2.10 M
+$714.00 K+51.48%
December 31, 2023
Summary
- As of February 7, 2025, RNA annual depreciation & amortization is $2.10 million, with the most recent change of +$714.00 thousand (+51.48%) on December 31, 2023.
- During the last 3 years, RNA annual D&A has risen by +$1.73 million (+463.27%).
- RNA annual D&A is now at all-time high.
Performance
RNA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$710.00 K
+$23.00 K+3.35%
September 1, 2024
Summary
- As of February 7, 2025, RNA quarterly depreciation & amortization is $710.00 thousand, with the most recent change of +$23.00 thousand (+3.35%) on September 1, 2024.
- Over the past year, RNA quarterly D&A has increased by +$144.00 thousand (+25.44%).
- RNA quarterly D&A is now at all-time high.
Performance
RNA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$2.65 M
+$144.00 K+5.74%
September 1, 2024
Summary
- As of February 7, 2025, RNA TTM depreciation & amortization is $2.65 million, with the most recent change of +$144.00 thousand (+5.74%) on September 1, 2024.
- Over the past year, RNA TTM D&A has increased by +$786.00 thousand (+42.10%).
- RNA TTM D&A is now at all-time high.
Performance
RNA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
RNA Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.5% | +25.4% | +42.1% |
| 3 y3 years | +463.3% | +303.4% | +385.9% |
| 5 y5 years | +448.6% | +745.2% | +662.4% |
RNA Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +228.8% | at high | +241.3% | at high | +315.2% |
| 5 y | 5-year | at high | +503.7% | at high | +859.5% | at high | +718.8% |
| alltime | all time | at high | +503.7% | at high | +859.5% | at high | +2752.7% |
Avidity Biosciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $710.00 K(+3.3%) | $2.65 M(+5.7%) |
| Jun 2024 | - | $687.00 K(+7.2%) | $2.51 M(+6.7%) |
| Mar 2024 | - | $641.00 K(+4.2%) | $2.35 M(+11.9%) |
| Dec 2023 | $2.10 M(+51.5%) | $615.00 K(+8.7%) | $2.10 M(+12.5%) |
| Sep 2023 | - | $566.00 K(+7.0%) | $1.87 M(+11.7%) |
| Jun 2023 | - | $529.00 K(+35.3%) | $1.67 M(+14.1%) |
| Mar 2023 | - | $391.00 K(+2.6%) | $1.46 M(+5.6%) |
| Dec 2022 | $1.39 M(+117.1%) | $381.00 K(+3.0%) | $1.39 M(+14.3%) |
| Sep 2022 | - | $370.00 K(+14.9%) | $1.21 M(+19.0%) |
| Jun 2022 | - | $322.00 K(+2.5%) | $1.02 M(+20.7%) |
| Mar 2022 | - | $314.00 K(+51.0%) | $845.00 K(+32.2%) |
| Dec 2021 | $639.00 K | $208.00 K(+18.2%) | $639.00 K(+17.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $176.00 K(+19.7%) | $546.00 K(+15.9%) |
| Jun 2021 | - | $147.00 K(+36.1%) | $471.00 K(+18.3%) |
| Mar 2021 | - | $108.00 K(-6.1%) | $398.00 K(+6.7%) |
| Dec 2020 | $373.00 K(+7.2%) | $115.00 K(+13.9%) | $373.00 K(+9.4%) |
| Sep 2020 | - | $101.00 K(+36.5%) | $341.00 K(+5.2%) |
| Jun 2020 | - | $74.00 K(-10.8%) | $324.00 K(-4.1%) |
| Mar 2020 | - | $83.00 K(0.0%) | $338.00 K(-2.9%) |
| Dec 2019 | $348.00 K(-9.1%) | $83.00 K(-1.2%) | $348.00 K(+31.3%) |
| Sep 2019 | - | $84.00 K(-4.5%) | $265.00 K(+46.4%) |
| Jun 2019 | - | $88.00 K(-5.4%) | $181.00 K(+94.6%) |
| Mar 2019 | - | $93.00 K | $93.00 K |
| Dec 2018 | $383.00 K | - | - |
FAQ
- What is Avidity Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Avidity Biosciences?
- What is Avidity Biosciences annual D&A year-on-year change?
- What is Avidity Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Avidity Biosciences?
- What is Avidity Biosciences quarterly D&A year-on-year change?
- What is Avidity Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Avidity Biosciences?
- What is Avidity Biosciences TTM D&A year-on-year change?
What is Avidity Biosciences annual depreciation & amortization?
The current annual D&A of RNA is $2.10 M
What is the all time high annual D&A for Avidity Biosciences?
Avidity Biosciences all-time high annual depreciation & amortization is $2.10 M
What is Avidity Biosciences annual D&A year-on-year change?
Over the past year, RNA annual depreciation & amortization has changed by +$714.00 K (+51.48%)
What is Avidity Biosciences quarterly depreciation & amortization?
The current quarterly D&A of RNA is $710.00 K
What is the all time high quarterly D&A for Avidity Biosciences?
Avidity Biosciences all-time high quarterly depreciation & amortization is $710.00 K
What is Avidity Biosciences quarterly D&A year-on-year change?
Over the past year, RNA quarterly depreciation & amortization has changed by +$144.00 K (+25.44%)
What is Avidity Biosciences TTM depreciation & amortization?
The current TTM D&A of RNA is $2.65 M
What is the all time high TTM D&A for Avidity Biosciences?
Avidity Biosciences all-time high TTM depreciation & amortization is $2.65 M
What is Avidity Biosciences TTM D&A year-on-year change?
Over the past year, RNA TTM depreciation & amortization has changed by +$786.00 K (+42.10%)